Experience, Access to Care and Support

How to Apply: 

Researchers are invited to apply for a new grant funding opportunity to conduct a study to explore the experiences of women and diverse members related to undesired reproductive outcomes during their service in the Canadian Armed Forces (CAF). The Canadian Forces Health Services (CFHS) Director of Women and Diversity Health (D WDH) has identified infertility, pregnancy loss, and adverse pregnancy outcomes as areas of specific interest, but researchers are encouraged to explore other focus areas as well, to better understand how these are or were experienced during service by women and diverse members or Veterans, to identify possible gaps in prevention, care and supports, or barriers to receiving care and supports that may exist for these populations.

External Deadline: 
Friday, October 25, 2024
Funding Source: 
External
Funding Level: 
Research

Other: Planning and Dissemination Grants – ICS (Winter 2025)

How to Apply: 

The specific objectives of this funding opportunity are to support:

  • planning activities, partnership development and to increase understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of CIHR; and
  • dissemination events and activities that focus on the communication of health research evidence to the appropriate researcher or knowledge-user audiences, tailoring the message and medium as appropriate.
External Deadline: 
Tuesday, November 19, 2024
Funding Source: 
External
Funding Level: 
Research

Catalyst Grant: Digital Health

How to Apply: 

The specific objectives of this funding opportunity are to:

  • Support original, high quality research in digital health that has the potential to generate pilot data for future research (e.g. Project Grant and funding at other Agencies/Councils), including research into evaluation, scale up, or implementation of a digital health product, platform or application.
  • Incentivize research that focuses on digital health solutions for the CIHR-IMHA mandate areas.
  • Foster a community of CIHR-IMHA digital health researchers that partner with Canadian leaders in equitable digital science.
  • Provide research leadership, stimulate innovative research and practice, and strengthen research capacity by dedicating funds to early and mid-career researchers as part of CIHR-IMHA’s commitment to Nurture Leaders.
  • Strengthen health research through the incorporation of patient and/or community engagement.
External Deadline: 
Tuesday, December 3, 2024
Funding Source: 
External
Funding Level: 
Research

Ontario’s Action Plan to End Gender-Based Violence: Call for Proposals

How to Apply: 

As part of Ontario’s four-year cross-government action plan to prevent and address gender-based violence, we are investing in new community-based programs and services that respond to the needs of victims, survivors and their families and communities

Ontario is investing $100 million over the next three years in new gender-based violence services and supports that prevent violence and address the needs of local communities and populations in four key areas:

  1. education and awareness
  2. early intervention and prevention
  3. community planning and service integration
  4. economic security and financial independence

Successful proposals will include innovative, evidence-based projects that:

  • support people who are most vulnerable to experiencing gender-based violence
  • support survivors of gender-based violence and their families
  • address the root causes of gender-based violence

Please contact the Office of Research if you are interested in this opportunity.

External Deadline: 
Friday, October 11, 2024
Funding Source: 
External
Funding Level: 
Research

Ministry of Children, Community and Social Services

Ontario Vehicle Innovation Network (OVIN): R&D Partnership Fund – Advanced Charging and Vehicle-to-Grid (V2G) Stream

Eligibility: 

Eligible Applicants

  • A small- and medium- sized enterprise (SME) with fewer than 500 global full-time employees.
  • May be an Applicant on only one R&D Partnership Fund project at a time.
  • Must have registered operations (R&D, manufacturing, product management, etc.) in Ontario.
  • Applicants who have received over $500,000 of funding from OCI administered programs in their lifetime (excluding TalentEdge) are required to obtain OCI approval before a new application for funding is initiated. Your Business Development Manager can guide you through the process.

Eligible partners

  • Small and Medium-Sized Enterprises (SMEs)
  • National and Multi-National Enterprises (NEs and MNEs)
  • Academic institutions (as clients only)
  • Local electricity utilities or local distribution companies (LDCs)
  • Municipalities
  • Transit Authorities
  • Crown Corporations
  • Indigenous Communities
  • Not-For-Profit Organizations representing industry
How to Apply: 

The R&D Partnership Fund – Advanced Charging and V2G Stream supports projects related to the development, validation, testing, piloting, demonstration, commercialization, and deployment of technologies, products and services focused on advanced charging and V2G technologies needed to accelerate the shift to electrification. This includes technologies in the following Priority Areas:

  • Advanced charging technologies, including wireless charging, high-speed charging, bidirectional charging, dynamic charging, and smart charging.
  • Vehicle-to-Grid (V2G) technologies, including technologies to support interoperability and scalability.
  • Energy demand and grid management systems.
  • Zero-emissions technologies relating to the integration of renewable energy within charging infrastructure.
  • Energy storage and transmission technologies (including battery and hydrogen-focused technologies) relating to energy management and grid capacity.
External Deadline: 
Wednesday, October 2, 2024
Funding Source: 
External
Funding Level: 
Research

OECD - CRP Applications for Events (Conferences, Workshops, Symposiums)

How to Apply: 
Applications are invited from research scientists working in agriculture, forestry or fisheries for funding towards an event (conference, workshop, symposium, etc) to take place in a member country of the Co-operative Research Programme. The aim of the Event Sponsorship scheme is to inform policy makers, industry and academia about current and future research, scientific developments and innovations in these areas.
 
For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.
External Deadline: 
Tuesday, September 10, 2024
Funding Source: 
External
Funding Level: 
Research

OECD - CRP Research Fellowships

How to Apply: 

Applications are invited from research scientists working in agriculture, forestry or fisheries who would like to conduct research projects abroad, in another member country of the Co-operative Research Programme from 6 to 26 weeks. The aim of the Research Fellowships is to strengthen the international exchange of ideas and increase international mobility and co-operation among scientists working in these areas.

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

External Deadline: 
Tuesday, September 10, 2024
Funding Source: 
External
Funding Level: 
Research

Organisation for Economic Co-operation and Development

Call for Applications

How to Apply: 

The Canadian Hemophilia Society (CHS) is proud to put out its call for applications for its research programs for the 2025-2026 grant period. The deadline to submit applications for all the programs is November 29, 2024. The eligibility criteria and conditions for all our research programs have been revised and updated. Of note, applications must now be done on-line at the links provided on our website under each research program heading and, eligibility has been expanded as follows:

Dream of a Cure: the program is no longer limited to hemophilia A & B-related projects so that projects focusing on von Willebrand disease, rare factor deficiencies, platelet function disorders (and platelet pathophysiology) and other congenital and acquired bleeding disorders can be supported;

Dream of a Cure Studentships in Inherited Bleeding Disorders Research: similarly to our basic scientific research program, the studentships are no longer limited to hemophilia-related projects but include all inherited bleeding disorders. Furthermore, science students in any year of an undergraduate program can apply in addition to medical students in any year of training;

CHS/Pfizer Care Until Cure Research Program: the areas of interest to which investigators are encouraged to submit proposals has been expanded to include assessing joint function, FIX/FVIII assay discrepancy across gene therapy recipients, methodology for monitoring patients treated with anti-TFPI therapies; all projects included but not limited to the list will be considered;

CHS/Novo Nordisk Psychosocial Research Programme: applications from Social Workers, Nurses, or Physiotherapists with professional experience in a hemophilia treatment centre (or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders) or persons interested in the field of inherited bleeding disorders will be considered. Students in a PhD program in one of the allied health disciplines may also apply. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Professional experience in a hemophilia treatment centre is desirable but not required.

CHS/Bayer ADVANCE Canada Research Program:  applicant must be a physician or Ph.D. or professionals from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) with professional experience in a hemophilia treatment centre (HTC) or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. The proposed research must have relevance to current practice in bleeding disorders care and may incorporate a broad spectrum of quantitative and qualitative research methods addressing professional practice with individuals, families, groups and communities, organizational issues, public health, and education. The research studies should aim to provide better data and tools to help the treaters assist patients in successful ageing.

 

DREAM OF A CURE

 

Through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides basic scientific research grants and studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, finding a cure.

 

Dream of a Cure, the CHS Research Program and the 2025 Dream of a Cure Summer Studentships in Inherited Bleeding Disorders Research on-line application forms links as well as the general criteria and conditions are available by accessing the CHS Web site at https://www.hemophilia.ca/chs-dream-of-a-cure-research-program/. For Dream of a Cure, individual grants will be awarded to researchers for one to two years for amounts up to $75,000 per year while support will be offered to interested Canadian medical or science students for up to 4 months for a maximum stipend of $6,000 per student. 

 

______________________________

 

CHS / PFIZER CARE UNTIL CURE RESEARCH PROGRAM

You will find at https://www.hemophilia.ca/the-chspfizer-care-until-cure-research-program/ the information and the on-line application link for the CHS/Pfizer Care until Cure Research Program offered by the CHS in collaboration with Pfizer Canada. This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders. Grants for one to two years with a maximum of $75,000 per year will be awarded for clinical research, including outcome evaluation, in fields relevant to improving the health and the quality of life for persons with Hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C infection, and carriers of an inherited bleeding disorder.

 
______________________________

 

 

CHS/Novo Nordisk canada Psychosocial Research Programme

 

The CHS/Novo Nordisk Canada Psychosocial Research Program was created to engage hemophilia program professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.

 

The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.Depending upon the number and quality of applications, funding for different amounts is possible, as is the offering of more than one research grant, within however, the allotted total budget stated above.

 

The major portion of the grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses.

 

Multidisciplinary Collaboration:
Collaboration with multidisciplinary care providers and/or between two or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. It thus may be possible for a hemophilia centre team to jointly submit a cooperative research project. Additionally, inter-regional applications will be considered.
 
Grants will be offered for a one-year period to begin in April 2025.

 

More detailed information and the on-line application link are available by accessing the CHS Web site at https://www.hemophilia.ca/the-chsnovo-nordisk-psychosocial-research-program/

 

______________________________

 

 

The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program

 

 

The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population.

 

The research program will support studies that aim to:

 

•             Identify and provide insight into key issues associated with the ageing hemophilia population

•             Identify how management of age-related co-morbidities should be adapted to those with hemophilia

•             Create and deliver evidence-based information to health care practitioners (HCPs), the public and policy makers that will lead to improved care and QoL for older Canadians living with hemophilia

 

The primary intent of this program is to offer one or two $22,500 research grants, to a maximum of $45,000 for one year. Depending upon the number and quality of applications, funding for different amounts is possible, as is the offering of more than one research grant, within however, the allotted total budget stated above.

 

Additional information, the on-line application link, the eligibility criteria and conditions for the research program can be found on our website at this link:

https://www.hemophilia.ca/research-chs-bayer-advance-canada-research-program/

 

External Deadline: 
Friday, November 29, 2024
Funding Source: 
External
Funding Level: 
Research
Undergraduate

Pages